aldose reductase inhibitors (University of Texas Medical Branch at Galveston)

N/A

Report date: 2025/03/18 18:03:56
NME

Base Information

Drug Namealdose reductase inhibitors (University of Texas Medical Branch at Galveston)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsInflammationAutoimmune DiseasesPulmonary Disease, Chronic Obstructive +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas Medical Branch
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Texas Medical Branch
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesPulmonary Disease, Chronic Obstructive +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A